{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T12:04:01Z","timestamp":1785153841870,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012655","name":"Shandong University Qilu Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong","doi-asserted-by":"publisher","award":["2025KJHZ039"],"award-info":[{"award-number":["2025KJHZ039"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.nbd.2026.107416","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:15:37Z","timestamp":1777011337000},"page":"107416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Plasma proteome and autism spectrum disorder: Integrative proteome-wide Mendelian randomization with clinical profiling"],"prefix":"10.1016","volume":"224","author":[{"given":"Lihong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianci","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianhu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2026.107416_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1716197","article-title":"The role of interleukin-37 and interleukin-38 in the development and remission of autism spectrum disorder: a comprehensive review of neuroinflammatory mechanisms and potential therapeutic implications","volume":"16","author":"Al Rasbi","year":"2025","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.nbd.2026.107416_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087475","article-title":"Upregulation of inflammatory mediators in peripheral blood CD40(+) cells in children with autism spectrum disorder","volume":"24","author":"Aldossari","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.nbd.2026.107416_bb0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbi.2010.08.003","article-title":"Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome","volume":"25","author":"Ashwood","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.nbd.2026.107416_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1185021","article-title":"Olink proteomics profiling platform reveals non-invasive inflammatory related protein biomarkers in autism spectrum disorder","volume":"16","author":"Bao","year":"2023","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.nbd.2026.107416_bb0025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41590-017-0004-z","article-title":"Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy","volume":"19","author":"Barkal","year":"2018","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.nbd.2026.107416_bb0030","first-page":"191","article-title":"Diagnostic and statistical manual of mental disorders (DSM)","volume":"25","author":"Battle","year":"2013","journal-title":"Codas"},{"issue":"4","key":"10.1016\/j.nbd.2026.107416_bb0035","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/jrsm.1346","article-title":"Meta-analysis and Mendelian randomization: a review","volume":"10","author":"Bowden","year":"2019","journal-title":"Res. Synth. Methods"},{"issue":"1","key":"10.1016\/j.nbd.2026.107416_bb0040","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2019.6","article-title":"An atlas of genetic correlations between psychiatric disorders and human blood plasma proteome","volume":"63","author":"Cheng","year":"2020","journal-title":"Eur. Psychiatry"},{"issue":"2","key":"10.1016\/j.nbd.2026.107416_bb0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molmed.2008.12.001","article-title":"C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress","volume":"15","author":"Cugno","year":"2009","journal-title":"Trends Mol. Med."},{"issue":"R1","key":"10.1016\/j.nbd.2026.107416_bb0050","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.nbd.2026.107416_bb0055","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00787-020-01587-4","article-title":"ESCAP practice guidance for autism: A summary of evidence-based recommendations for diagnosis and treatment","volume":"30","author":"Fuentes","year":"2021","journal-title":"Eur. Child Adolesc. Psychiatry"},{"issue":"9","key":"10.1016\/j.nbd.2026.107416_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ph16091286","article-title":"Revisiting p38 mitogen-activated protein kinases (MAPK) in inflammatory arthritis: a narrative of the emergence of MAPK-activated protein kinase inhibitors (MK2i)","volume":"16","author":"Ganguly","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"10.1016\/j.nbd.2026.107416_bb0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cels.2016.02.015","article-title":"Plasma proteome profiling to assess human health and disease","volume":"2","author":"Geyer","year":"2016","journal-title":"Cell Syst."},{"key":"10.1016\/j.nbd.2026.107416_bb0070","article-title":"Plasma proteome profiling to detect and avoid sample-related biases in biomarker studies","volume":"11","author":"Geyer","year":"2019","journal-title":"EMBO Mol. Med.11"},{"issue":"3","key":"10.1016\/j.nbd.2026.107416_bb0075","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41588-019-0344-8","article-title":"Identification of common genetic risk variants for autism spectrum disorder","volume":"51","author":"Grove","year":"2019","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.nbd.2026.107416_bb0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/jama.2022.23661","article-title":"Autism spectrum disorder","volume":"329","author":"Hirota","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.nbd.2026.107416_bb0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/cns.13569","article-title":"Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms","volume":"27","author":"Huang","year":"2021","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.nbd.2026.107416_bb0090","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-94-017-7215-0_9","article-title":"Neuron-specific enolase as a biomarker: biochemical and clinical aspects","volume":"867","author":"Isgr\u00f2","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1\u20132","key":"10.1016\/j.nbd.2026.107416_bb0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneuroim.2008.12.002","article-title":"Elevated immune response in the brain of autistic patients","volume":"207","author":"Li","year":"2009","journal-title":"J. Neuroimmunol."},{"issue":"8","key":"10.1016\/j.nbd.2026.107416_bb0100","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1007\/s12035-020-01976-5","article-title":"Postmortem studies of neuroinflammation in autism spectrum disorder: a systematic review","volume":"57","author":"Liao","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2026.107416_bb0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.molmed.2008.02.004","article-title":"The NKG2D receptor: sensing stressed cells","volume":"4","author":"L\u00f3pez-Larrea","year":"2008","journal-title":"Trends Mol. Med.14"},{"issue":"1","key":"10.1016\/j.nbd.2026.107416_bb0110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev-publhealth-031816-044318","article-title":"The changing epidemiology of autism spectrum disorders","volume":"38","author":"Lyall","year":"2017","journal-title":"Annu. Rev. Public Health"},{"issue":"2","key":"10.1016\/j.nbd.2026.107416_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7202a1","article-title":"Prevalence and characteristics of autism spectrum disorder among children aged 8 years \u2014 autism and developmental disabilities monitoring network, 11 sites, United States, 2020","volume":"72","author":"Maenner","year":"2023","journal-title":"MMWR Surveill. Summ."},{"issue":"1","key":"10.1016\/j.nbd.2026.107416_bb0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1176\/appi.ajp.2020.20111608","article-title":"Autism spectrum disorder genetics and the search for pathological mechanisms","volume":"178","author":"Manoli","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.nbd.2026.107416_bb0125","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbi.2019.04.037","article-title":"The influence of neuroinflammation in autism spectrum disorder","volume":"79","author":"Matta","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.nbd.2026.107416_bb0130","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1042\/BJ20071149","article-title":"Roles for TAB1 in regulating the IL-1-dependent phosphorylation of the TAB3 regulatory subunit and activity of the TAK1 complex","volume":"409","author":"Mendoza","year":"2008","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.nbd.2026.107416_bb0135","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/jnc.14574","article-title":"The S100\u0392 story: from biomarker to active factor in neural injury","volume":"148","author":"Michetti","year":"2019","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.nbd.2026.107416_bb0140","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/1362361310379241","article-title":"Use of the autism diagnostic observation schedule (ADOS) in a clinical setting","volume":"15","author":"Molloy","year":"2011","journal-title":"Autism"},{"key":"10.1016\/j.nbd.2026.107416_bb0145","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.bcp.2010.06.021","article-title":"MAPKAP kinases MK2 and MK3 in inflammation: complex regulation of TNF biosynthesis via expression and phosphorylation of tristetraprolin","volume":"12","author":"onkina","year":"2010","journal-title":"Biochem. Pharmacol.80"},{"issue":"4","key":"10.1016\/j.nbd.2026.107416_bb0150","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-0031-1276582","article-title":"Heparin cofactor II: discovery, properties, and role in controlling vascular homeostasis","volume":"37","author":"Rau","year":"2011","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.nbd.2026.107416_bb0155","series-title":"Autism treatment evaluation checklist","author":"Rimland","year":"1999"},{"issue":"10","key":"10.1016\/j.nbd.2026.107416_bb0160","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1096\/fj.05-5619fje","article-title":"Interaction of HIV tat and matrix metalloproteinase in HIV neuropathogenesis: a new host defense mechanism","volume":"20","author":"Rumbaugh","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2026.107416_bb0165","series-title":"The Childhood Autism Rating Scale (CARS) for Diagnostic Screening and Classification of Autism","first-page":"63","author":"Schopler","year":"1986"},{"issue":"17","key":"10.1016\/j.nbd.2026.107416_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713404","article-title":"Metabolomics: perspectives on clinical employment in autism spectrum disorder","volume":"24","author":"Siracusano","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.nbd.2026.107416_bb0175","article-title":"Connecting genetic risk to disease end points through the human blood plasma proteome","volume":"8","author":"Suhre","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2026.107416_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103948","article-title":"Association between plasma proteome and childhood neurodevelopmental disorders: a two-sample Mendelian randomization analysis","volume":"78","author":"Yang","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.nbd.2026.107416_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1015128","article-title":"Complement C1s as a diagnostic marker and therapeutic target: progress and propective","volume":"13","author":"Ye","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126001610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126001610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:29:51Z","timestamp":1785151791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996126001610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":37,"alternative-id":["S0969996126001610"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107416","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma proteome and autism spectrum disorder: Integrative proteome-wide Mendelian randomization with clinical profiling","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107416","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107416"}}